Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
5	4	Search

2025	MEF2C is a potential prognostic biomarker for osteosarcoma Medicine Zhihui Zheng, Zhicheng Liao, Liang Pang, Zhouhengte Xu, Yibo Zhu, Pengcheng Jia, Qinglai Wang
2025	Osteosarcoma immunometabolism: emerging mechanisms and clinical implications Frontiers in Immunology Bowen Tan, Jingyuan Ning
2025	FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2 Journal of Cancer Research and Clinical Oncology Kongyan Zhang, Fei Zhang, Jiahe Wang
2025	Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors Frontiers in Immunology Weixin Zhang, Yile Xu, Yingjin Fang, Meng Li, Di Li, Huiqin Guo, Hang Li, Jing He, Lei Miao
2024	USP22 Promotes Osteosarcoma Progression by Stabilising β‐Catenin and Upregulating HK2 and Glycolysis Journal of Cellular and Molecular Medicine Shenliang Chen, Xin Hu, Xuan Yi, Xueqiang Deng, Ting Xiong, Yanghuan Ou, Shuaigang Liu, Chen Li, Xiaohua Yan, Liang Hao